Statistical Process Control in Tomotherapy Pre-Treatment QA

Modern radiotherapy relies on extremely precise dose delivery. Techniques such as Intensity-Modulated Radiation Therapy (IMRT) and helical Tomotherapy allow clinicians to shape radiation doses with remarkable accuracy, targeting tumors while protecting surrounding healthy tissues.

However, this level of precision requires rigorous quality assurance (QA) procedures. Before a treatment plan is delivered to a patient, it must be verified to ensure that the calculated dose distribution matches the dose that will actually be delivered by the treatment machine.

One powerful approach to improving this verification process is the application of Statistical Process Control (SPC).

Quality Assurance in Tomotherapy

In helical Tomotherapy, treatment is delivered while the machine rotates continuously around the patient. This creates complex dose distributions that must be carefully validated.

Patient-specific QA commonly involves:

Absolute dose measurements

Gamma index analysis

Detector arrays such as ArcCheck

Software verification using Tomotherapy DQA systems

These tools allow physicists to compare planned dose distributions with measured dose distributions, identifying potential deviations before treatment begins.

Applying Statistical Process Control (SPC)

Statistical Process Control is widely used in engineering and manufacturing to monitor system stability. When applied to radiotherapy QA, SPC helps physicists determine whether a treatment verification process is stable or drifting outside acceptable limits.

Key SPC concepts include:

Control limits

Tolerance limits

Action limits

Process stability

By analyzing QA results across multiple treatment plans, it becomes possible to establish statistically justified thresholds instead of relying only on generic pass/fail criteria.

Establishing Tolerance and Action Limits

Research on Tomotherapy QA has shown that SPC can be used to determine specific verification thresholds for different treatment sites, including:

Abdomen

Head and neck

Breast and supraclavicular region

Prostate

The analysis demonstrated that some treatment sites naturally exhibit greater variability in QA metrics due to anatomical complexity or dose distribution patterns.

For example:

Head and neck treatments often show stable QA performance.

Breast and abdominal treatments may present larger variations because of dose gradient complexity.

Using SPC allows medical physicists to distinguish between normal variation and true process deviations that require intervention.

Statistical monitoring transforms QA from a simple pass/fail check into a continuous evaluation of treatment delivery performance.

Benefits for Clinical Practice

Implementing SPC within Tomotherapy QA workflows provides several advantages:

Improved reliability of treatment verification

Early detection of systematic deviations

Better understanding of machine and plan variability

More meaningful QA thresholds based on real data

Enhanced patient safety

Instead of applying universal limits to all treatment types, SPC allows institutions to adapt QA criteria based on their own clinical datasets.

Toward Data-Driven Radiotherapy QA

As radiotherapy techniques become increasingly complex, data-driven quality assurance methods are becoming essential.

Combining:

detector-based measurements,

gamma index analysis,

and statistical process monitoring

creates a robust framework for maintaining high standards in treatment delivery.

These approaches support the broader goal of precision radiotherapy, where every treatment is verified, monitored, and continuously improved through statistical analysis and clinical experience.

Author: Rosa Petit

Field: Medical Physics – Radiotherapy Quality Assurance